GSK and Pfizer agree £10bn healthcare merger



GlaxoSmithKline (GSK), is to merge its client healthcare unit with that of rival Pfizer, to create a brand new enterprise with virtually £10bn in annual gross sales.

Leave a Reply

Your email address will not be published. Required fields are marked *

*